Among the AS regulators with altered activity in cancer cells, heterogeneous nuclear ribonucleoprotein L (hnRNPL) has been largely described, initially as a splicing factor [11], then, more recently, as a regulator of RNA transcription and stability [12]. The gene discussed is HNRNPL; the disease is cancer.